New Deal
Rob Sharps
President and CEO at T. ROWE PRICE GROUP INC
Investor
Deal Bio
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.
Oak Hill Advisors
T. Rowe Price Group
£3,054m
63 dealmakers
Tessera Therapeutics
Abu Dhabi Investment Authority (adia)
£230m
26 dealmakers
CONVOY
Baillie Gifford & Co
£199m
13 dealmakers
Kobold Metals
Canada Pension Plan Investment Board
£141m
9 dealmakers
CLEERLY
Mirae Asset Capital Co
£159m
CELONIS
Qatar Investment Authority
£339m
40 dealmakers
CAPSULE
£267m
5 dealmakers
ANDPAD
Dnx Ventures
£58m
7 dealmakers
Saluda Medical
Redmile Group
£120m
8 dealmakers
Chroma Medicine
Arch Venture Partners
£111m
18 dealmakers
£152m
Genesis Therapeutics
Andreessen Horowitz
£156m
12 dealmakers
SANDBOXAQ
Breyer Capital
£410m